Kai kaal erichal kudineer for Diabetic neuropathy

Efficacy of Kai kaal erichal kudineer for Karathambam (Diabetic Neuropathy) among patients attending OPD at Government Siddha Medical College Hospital Chennai - A Pilot Study - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072416

Enrollment

Registered

2024-08-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G629- Polyneuropathy, unspecified

Interventions

Intervention1: Kai kaal erichal kudineer for Diabetic Neuropathy: Pachai payaru (Vigna radiata) -10 grams Kadukkai(Terminalia chebula) -10 grams Sukku(Zingiber officinale) -1

Eligibility

Inclusion criteria

Inclusion criteria: K/C/O Type 2 Diabetes Mellitus for past 5 years Stage N2a and N2b (NCBI staging of Diabetic Neuropathy)

Exclusion criteria

Exclusion criteria: Insulin dependent Diabetes Mellitus Alcohol-associated neuropathy Nutritional linked neuropathy Uremic neuropathy Vulnerable people

Design outcomes

Primary

Measure	Time frame
Grading of sign and symptoms. Physical examination: · Inspection of the feet for evidence of dry skin, hair or nail abnormalities, callus or infection or any deformity of foot. · Examination of vibratory sensation at the dorsum of toe with a 128 Hz tuning fork. · Examination of Ankle reflex. Mono filament testTimepoint: 48 days	—

Secondary

Measure	Time frame
Outcome will be assessed by Measuring the reduction in severity of signs and symptoms using staging scales such as trasitioning from, N2b to N2a/ N1a/N0 N2a to N1a/N0 N1a to N0Timepoint: 48 days	—

Countries

India

Contacts

Public ContactS Shalini

Government Siddha Medical College Chennai

rangasamymenaka75@gmail.com9444669661

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026